Basics of the Cath Lab: TAVR Resources for CVPs, Fellows, and the Cath Curious-TAVR Fundamentals

Video Transcription

Video Summary

In a detailed educational session, Dr. Michael Rinaldi, an interventional cardiologist, emphasizes the significant advancements in Transcatheter Aortic Valve Replacement (TAVR). Over the past decade, TAVR has emerged from clinical trials to become the primary method for aortic valve replacement in the Western Hemisphere due to its minimally invasive nature. The procedure involves a percutaneous approach, typically scheduled in a hybrid OR or cath lab with conscious sedation, allowing most patients to return home the next day. The discussion covers the importance of a collaborative team approach, which includes cardiologists, cardiac surgeons, and various specialists to effectively diagnose and treat aortic stenosis, primarily using echocardiograms and CT scans for planning. The indication for TAVR primarily focuses on severe symptomatic aortic stenosis, with decision-making between surgical versus transcatheter approaches based on patient age and comorbidities. Advancements in technology have made TAVR viable for even asymptomatic patients in certain conditions when testing such as treadmill tests reveals vulnerabilities. The discussion also covers potential complications, such as strokes and vascular access issues, while emphasizing patient safety and procedure efficacy.

Asset Subtitle

Mike Rinaldi, MD, FSCAI; Hailey Barbee, RCIS; Catherine Shah, DNP

Keywords

Transcatheter Aortic Valve Replacement

TAVR

aortic

TAVI

aortic stenosis

minimally invasive

collaborative team approach

echocardiograms

patient safety

procedure efficacy

TAVR

aortic

TAVI